CN Patent

CN111603439B — 一种长效依匹哌唑原位相变凝胶注射剂及其制备方法

Assigned to YaoPharma Co Ltd · Expires 2024-12-17 · 1y expired

What this patent protects

本发明提供了一种长效依匹哌唑原位相变凝胶注射剂及其制备方法。该原位相变凝胶注射剂，是以磷脂为基质将水难溶性药物依匹哌唑溶解在NMP中制成可注射给药的缓释制剂，具有优良的物理及化学稳定性，药物释放时间可维持长达2个月。另外，其制备工艺简单、设备要求低，适合工业化生产。

USPTO Abstract

本发明提供了一种长效依匹哌唑原位相变凝胶注射剂及其制备方法。该原位相变凝胶注射剂，是以磷脂为基质将水难溶性药物依匹哌唑溶解在NMP中制成可注射给药的缓释制剂，具有优良的物理及化学稳定性，药物释放时间可维持长达2个月。另外，其制备工艺简单、设备要求低，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN111603439B
Jurisdiction
CN
Classification
—
Expires
2024-12-17
Drug substance claim
No
Drug product claim
No
Assignee
YaoPharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.